F-Prime Capital Partners, a venture group owned by the Johnson family, owners of Fidelity Investments, has invested in ABK Biomedical. F-Prime was one of two investors in a Series B round worth $30 million for the Canadian venture. F-Prime has also invested in RiskLens, a cyber risk management software group. F-Prime was one of five investors in a Series B round worth $20.6 million for the US-based group.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in
